LakeShore Biopharma Co., Ltd Net Asset Momentum
LakeShore Biopharma Co., Ltd net asset momentum. LakeShore Biopharma Co., Ltd (LSBCF) recorded a net asset momentum of -14.6% as of March 2025, with net assets of $499.75 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check LakeShore Biopharma Co., Ltd (LSBCF) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of LakeShore Biopharma Co., Ltd (2021–2025)
Net asset momentum of LakeShore Biopharma Co., Ltd from 2021 to 2025. This chart tracks LakeShore Biopharma Co., Ltd's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is -14.6%, with net assets of $499.75 Million USD as of March 2025. See LakeShore Biopharma Co., Ltd shareholders equity for net asset value and shareholders' equity analysis.
LakeShore Biopharma Co., Ltd Net Asset Momentum by Year (2021–2025)
LakeShore Biopharma Co., Ltd net asset momentum by year from 2021 to 2025. The table below shows the complete annual net asset history for LakeShore Biopharma Co., Ltd from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see how much is LakeShore Biopharma Co., Ltd worth.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $499.75 Million | $1.37 Billion | $867.91 Million | ▼ -14.6% |
| 2024 | $585.21 Million | $1.51 Billion | $927.82 Million | ▼ -19.7% |
| 2023 | $728.45 Million | $1.72 Billion | $991.30 Million | ▲ +303.2% |
| 2022 | $180.68 Million | $201.03 Million | $20.35 Million | ▲ +845631.8% |
| 2021 | $21.36K | $91.37K | $70.01K | — |